BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16283181)

  • 1. PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.
    Ishii K; Minoshima S
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1463-5. PubMed ID: 16283181
    [No Abstract]   [Full Text] [Related]  

  • 2. PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.
    Pupi A; Nobili FM
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1466-72. PubMed ID: 16283180
    [No Abstract]   [Full Text] [Related]  

  • 3. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
    Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer's disease imaging biomarkers?
    Valotassiou V; Angelidis G; Psimadas D; Tsougos I; Georgoulias P
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):969-971. PubMed ID: 33078261
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies.
    Gutfilen B; Valentini G
    Biomed Res Int; 2014; 2014():426892. PubMed ID: 25587535
    [No Abstract]   [Full Text] [Related]  

  • 8. Should PET replace SPECT for evaluating CAD? The end of the beginning.
    Di Carli MF; Hachamovitch R
    J Nucl Cardiol; 2006; 13(1):2-7. PubMed ID: 16464710
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
    Kaneko K; Sasaki M; Morioka T; Koga H; Abe K; Sawamoto H; Ohya N; Yoshiura T; Mihara F; Honda H
    Nucl Med Commun; 2006 Nov; 27(11):893-9. PubMed ID: 17021430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1571-2. PubMed ID: 18491087
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
    Jolepalem P; Balon HR; Wong CY; Wu D
    J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ga-67 SPECT: ave atque vale! Or have we bid a premature farewell to a trusted friend?
    Hicks RJ
    Leuk Lymphoma; 2006 Dec; 47(12):2440-2. PubMed ID: 17169787
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal imaging in epilepsy: SPECT and PET.
    Dupont P
    JBR-BTR; 2008; 91(6):258-61. PubMed ID: 19203001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET and SPECT in common neuropsychiatric disease.
    Tatsch K; Ell PJ
    Clin Med (Lond); 2006; 6(3):259-62. PubMed ID: 16826858
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging techniques in the assessment of myocardial hibernation.
    Underwood SR
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1209; author reply 1210-1. PubMed ID: 15197506
    [No Abstract]   [Full Text] [Related]  

  • 20. PET and SPECT in brain tumors and epilepsy.
    Horky LL; Treves ST
    Neurosurg Clin N Am; 2011 Apr; 22(2):169-84, viii. PubMed ID: 21435569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.